Thomas Walter

Also affiliated with Centre National de la Recherche Scientifique, Inserm, Université Paris Sciences et Lettres, Hospices Civils de Lyon, Hôpital Edouard Herriot, Centre de Recherche en Cancérologie de Lyon, École Nationale Supérieure des Mines de Paris

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network”.

LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network

Annals of Oncology(2023)10.1016/j.annonc.2023.10.048

N/A

0DataRank · unranked

7 citations

Thierry Lecomte, Julien Hadoux, Patricia Niccoli, Léa Saban-Roche, E. Gaye +15 more